The rocket company founded a quarter-century ago by billionaire Jeff Bezos made history Thursday with the pinpoint landing of ...

Welcome to Edition 8.19 of the Rocket Report! Thursday was a monumental day in launch history with Blue Origin’s New Glenn rocket not just taking off successfully, but with the first stage masterfully ...

After a weather delay dashed its first launch attempt over the weekend, Blue Origin’s New Glenn rocket has lifted off Thursday from Cape Canaveral, Florida.

At the IN-SPACe Model Rocketry and CANSAT India Student Competition 2024–25 held at Tamkuhiraj, Kushinagar in Uttar Pradesh ...

A ring and banner ceremony. Double overtime. NBA on NBC's return. The NBA is truly back. In the first game of the 2025-26 regular season, the Oklahoma City Thunder outlasted the Houston Rockets ...

The Rockets are considered one of the more intriguing teams in the NBA this season, so much so that they drew the opening night national TV game against the champion Thunder back on the NBC network ...

The Oklahoma City Thunder will host the Houston Rockets on Tuesday. They will kick off the 2025-26 regular season on Opening Night. Obviously, this will be the first matchup of the season between the ...

The Oklahoma City Thunder play the Houston Rockets on Thursday, and if you’re looking to do some last-minute betting research, you’re in luck! We’ll give you the latest point spread, money line odds ...

Mizuho analyst Joseph Catanzaro initiated coverage of Apogee Therapeutics (APGE) with an Outperform rating and $105 price target The firm believes the company’s APG777 is positioned to play a ...

As the Houston Rockets inch closer to opening night against the Oklahoma City Thunder, Head Coach Ime Udoka is finalizing his rotations and determining what his players can contribute to the team's ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

The biotech is floating a fresh issue of its common stock. Certain participants will be sold warrants in lieu of equity. 10 stocks we like better than Apogee Therapeutics › Apogee Therapeutics (NASDAQ ...